Elevated ERK/p90 ribosomal S6 kinase activity underlies audiogenic seizure susceptibility in fragile X mice

FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism

Darnell, J. C., Van Driesche, S. J., Zhang, C., Hung, K. Y. S., Mele, A., Fraser, C. E., Stone, E. F., Chen, C., Fak, J. J., Chi, S. W., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.013 · Cited by 2,072 · see citing works

Correction of Fragile X Syndrome in Mice

Dölen, G., Osterweil, E., Rao, B. S. S., Smith, G. B., Auerbach, B. D., Chattarji, S., & Bear, M. F. (2007) · Neuron · doi:10.1016/j.neuron.2007.12.001 · Cited by 979 · see citing works

Advancing the understanding of autism disease mechanisms through genetics

de la Torre-Ubieta, L., Won, H., Stein, J. L., & Geschwind, D. H. (2016) · Nature Medicine · doi:10.1038/nm.4071 · Cited by 827 · see citing works

The RSK family of kinases: emerging roles in cellular signalling

Anjum, R., & Blenis, J. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2509 · Cited by 777 · see citing works

RAS/ERK Signaling Promotes Site-specific Ribosomal Protein S6 Phosphorylation via RSK and Stimulates Cap-dependent Translation

Roux, P. P., Shahbazian, D., Vu, H., Holz, M. K., Cohen, M. S., Taunton, J., Sonenberg, N., & Blenis, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700906200 · Cited by 749 · see citing works

Regulation of Dendritic Spine Morphology and Synaptic Function by Shank and Homer

Sala, C., Piëch, V., Wilson, N. R., Passafaro, M., Liu, G., & Sheng, M. (2001) · Neuron · doi:10.1016/s0896-6273(01)00339-7 · Cited by 716 · see citing works

Group 1 mGluR-Dependent Synaptic Long-Term Depression: Mechanisms and Implications for Circuitry and Disease

Lüscher, C., & Huber, K. M. (2010) · Neuron · doi:10.1016/j.neuron.2010.01.016 · Cited by 627 · see citing works

The Autistic Neuron: Troubled Translation?

Kelleher, R. J., & Bear, M. F. (2008) · Cell · doi:10.1016/j.cell.2008.10.017 · Cited by 598 · see citing works

Dysregulation of mTOR signaling in fragile X syndrome

Sharma, A., Hoeffer, C. A., Takayasu, Y., Miyawaki, T., McBride, S. M., Klann, E., & Zukin, R. S. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3696-09.2010 · Cited by 557 · see citing works

The translation of translational control by FMRP: therapeutic targets for FXS

Darnell, J. C., & Klann, E. (2013) · Nature Neuroscience · doi:10.1038/nn.3379 · Cited by 491 · see citing works

Chronic Pharmacological mGlu5 Inhibition Corrects Fragile X in Adult Mice

Michalon, A., Sidorov, M., Ballard, T. M., Ozmen, L., Spooren, W., Wettstein, J. G., Jaeschke, G., Bear, M. F., & Lindemann, L. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.009 · Cited by 489 · see citing works

Altered Neuronal and Circuit Excitability in Fragile X Syndrome

Contractor, A., Klyachko, V. A., & Portera‐Cailliau, C. (2015) · Neuron · doi:10.1016/j.neuron.2015.06.017 · Cited by 425 · see citing works

A rapid Percoll gradient procedure for preparation of synaptosomes

Dunkley, P. R., Jarvie, P. E., & Robinson, P. J. (2008) · Nature Protocols · doi:10.1038/nprot.2008.171 · Cited by 410 · see citing works

Hypersensitivity to mGluR5 and ERK1/2 Leads to Excessive Protein Synthesis in the Hippocampus of a Mouse Model of Fragile X Syndrome

Osterweil, E. K., Krueger, D. D., Reinhold, K., & Bear, M. F. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3888-10.2010 · Cited by 384 · see citing works

Genetic Removal of p70 S6 Kinase 1 Corrects Molecular, Synaptic, and Behavioral Phenotypes in Fragile X Syndrome Mice

Bhattacharya, A., Kaphzan, H., Alvarez-Dieppa, A. C., Murphy, J. P., Pierre, P., & Klann, E. (2012) · Neuron · doi:10.1016/j.neuron.2012.07.022 · Cited by 316 · see citing works

Molecular Profiling of Activated Neurons by Phosphorylated Ribosome Capture

Knight, Z. A., Tan, K., Birsoy, K., Schmidt, S. F., Garrison, J. L., Wysocki, R. W., Emiliano, A. B., Ekstrand, M. I., & Friedman, J. M. (2012) · Cell · doi:10.1016/j.cell.2012.10.039 · Cited by 312 · see citing works

Dysregulation and restoration of translational homeostasis in fragile X syndrome

Richter, J. D., Bassell, G. J., & Klann, E. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn4001 · Cited by 275 · see citing works

Reduced Cortical Synaptic Plasticity and GluR1 Expression Associated with Fragile X Mental Retardation Protein Deficiency

Li, J., Pelletier, M. R., Perez-Velazquez, J. L., & Carlen, P. L. (2002) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2001.1085 · Cited by 268 · see citing works

Postadolescent Changes in Regional Cerebral Protein Synthesis: An<i>In Vivo</i>Study in the<i>Fmr1</i>Null Mouse

Qin, M., Kang, J., Burlin, T. V., Jiang, C., & Smith, C. B. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0093-05.2005 · Cited by 263 · see citing works

Excess phosphoinositide 3-kinase subunit synthesis and activity as a novel therapeutic target in fragile X syndrome

Gross, C., Nakamoto, M., Yao, X., Chan, C.-B., Yim, S. Y., Ye, K., Warren, S. T., & Bassell, G. J. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0402-10.2010 · Cited by 241 · see citing works

The trouble with spines in fragile X syndrome: density, maturity and plasticity

He, C. X., & Portera‐Cailliau, C. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.03.049 · Cited by 206 · see citing works

REST-dependent epigenetic remodeling promotes the developmental switch in synaptic NMDA receptors

Rodenas-Ruano, A., Chávez, A. E., Cossio, M. J., Castillo, P. E., & Zukin, R. S. (2012) · Nature Neuroscience · doi:10.1038/nn.3214 · Cited by 198 · see citing works

Shank synaptic scaffold proteins: keys to understanding the pathogenesis of autism and other synaptic disorders

Sala, C., Vicidomini, C., Bigi, I., Mossa, A., & Verpelli, C. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13232 · Cited by 173 · see citing works

Dysregulation of Mammalian Target of Rapamycin Signaling in Mouse Models of Autism

Huber, K. M., Klann, E., Costa-Mattioli, M., & Zukin, R. S. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2656-15.2015 · Cited by 167 · see citing works

Coffin–Lowry syndrome

Pereira, P. M., Schneider‐Anthony, A., Pannetier, S., Héron, D., & Hanauer, A. (2009) · European Journal of Human Genetics · doi:10.1038/ejhg.2009.189 · Cited by 137 · see citing works

Comparison of the specificities of p70 S6 kinase and MAPKAP kinase‐1 identifies a relatively specific substrate for p70 S6 kinase: the N‐terminal kinase domain of MAPKAP kinase‐1 is essential for peptide phosphorylation

Leighton, I. A., Dalby, K. N., Caudwell, F. B., Cohen, P. T. W., & Cohen, P. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01170-j · Cited by 126 · see citing works

The p90 RSK Family Members: Common Functions and Isoform Specificity

Lara, R., Seckl, M. J., & Pardo, O. E. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4448 · Cited by 125 · see citing works

Increased Expression of the PI3K Enhancer PIKE Mediates Deficits in Synaptic Plasticity and Behavior in Fragile X Syndrome

Gross, C., Chang, C.-W., Kelly, S. M., Bhattacharya, A., McBride, S. M. J., Danielson, S. W., Jiang, M. Q., Chan, C. B., Ye, K., Gibson, J. R., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.03.060 · Cited by 117 · see citing works

Impaired inhibitory control of cortical synchronization in fragile X syndrome

Paluszkiewicz, S. M., Olmos-Serrano, J. L., Corbin, J. G., & Huntsman, M. M. (2011) · Journal of Neurophysiology · doi:10.1152/jn.00421.2011 · Cited by 107 · see citing works

Region-specific effects of acute and repeated restraint stress on the phosphorylation of mitogen-activated protein kinases

Meller, E., Shen, C., Nikolao, T. A., Jensen, C. H., Tsimberg, Y., Chen, J., & Gruen, R. J. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02866-x · Cited by 105 · see citing works

Deletion of the Coffin–Lowry Syndrome Gene Rsk2 in Mice is Associated With Impaired Spatial Learning and Reduced Control of Exploratory Behavior

Poirier, R., Jacquot, S., Vaillend, C., Soutthiphong, A. A., Libbey, M., Davis, S., Laroche, S., Hanauer, A., Welzl, H., Lipp, H., et al. (2006) · Behavior Genetics · doi:10.1007/s10519-006-9116-1 · Cited by 87 · see citing works

Ribosomal S6 kinase 2 interacts with and phosphorylates PDZ domain-containing proteins and regulates AMPA receptor transmission

Thomas, G. M., Rumbaugh, G., Harrar, D. B., & Huganir, R. L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507476102 · Cited by 85 · see citing works

Phosphatidylinositol 3-Kinase Activation Is Required for Stress Protocol-induced Modification of Hippocampal Synaptic Plasticity

Yang, P.-C., Yang, C. H., Huang, C., & Hsu, K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706954200 · Cited by 83 · see citing works

Inhibition of ERK‐MAP kinase signaling by RSK during Drosophila development

Kim, M.-J., Lee, J. H., Koh, H., Lee, S. Y., Jang, C., Chung, C. J., Sung, J. H., Blenis, J., & Chung, J. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601180 · Cited by 72 · see citing works

Excess Protein Synthesis in FXS Patient Lymphoblastoid Cells Can Be Rescued with a p110β-Selective Inhibitor

Groß, C., & Bassell, G. J. (2011) · Molecular Medicine · doi:10.2119/molmed.2011.00363 · Cited by 69 · see citing works

Overcoming resistance to sonic hedgehog inhibition by targeting p90 ribosomal S6 kinase in pediatric medulloblastoma

Pambid, M. R., Berns, R., Adomat, H. H., Hu, K., Triscott, J., Maurer, N., Zisman, N., Ramaswamy, V., Hawkins, C. E., Taylor, M. D., et al. (2013) · Pediatric Blood & Cancer · doi:10.1002/pbc.24675 · Cited by 60 · see citing works

Pharmacological Rescue of Cortical Synaptic and Network Potentiation in a Mouse Model for Fragile X Syndrome

Chen, T., Lu, J.-S., Song, Q., Liu, M.-G., Koga, K., Descalzi, G., Li, Y.-Q., & Zhuo, M. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.44 · Cited by 52 · see citing works

Elevated CaMKIIα and Hyperphosphorylation of Homer Mediate Circuit Dysfunction in a Fragile X Syndrome Mouse Model

Guo, W., Ceolin, L., Collins, K. A., Perroy, J., & Huber, K. M. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.11.013 · Cited by 51 · see citing works

Dysregulation of mTOR Signaling in Neuropsychiatric Disorders: Therapeutic Implications

Sawicka, K., & Zukin, R. S. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.210 · Cited by 41 · see citing works

The p90 ribosomal S6 kinase (RSK) inhibitor BI-D1870 prevents gamma irradiation-induced apoptosis and mediates senescence via RSK- and p53-independent accumulation of p21WAF1/CIP1

Neise, D., Sohn, D., Stefanski, A., Goto, H., Inagaki, M., Wesselborg, S., Budach, W., Stühler, K., & Jänicke, R. U. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.386 · Cited by 38 · see citing works

Fragile X Syndrome: Psychiatric Manifestations, Assessment and Emerging Therapies

Wadell, P. M., Hagerman, R. J., & Hessl, D. R. (2013) · Current Psychiatry Reviews · doi:10.2174/157340013805289644 · Cited by 32 · see citing works

Altered ERK/MAPK signaling in the hippocampus of the mrsk2_KO mouse model of Coffin‐Lowry syndrome

Schneider‐Anthony, A., Mehmood, T., Pannetier, S., & Hanauer, A. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07423.x · Cited by 30 · see citing works

Abstract 5301: Integrated array CGH and expression profiling revealed candidate biomarkers in gastrointestinal stromal tumors.

Kang, G., Lee, E. J., Kang, S. W., Jang, K., Lee, J., Park, J. O., Park, C. K., Sohn, T. S., Kim, S., Do, I., et al. (2013) · Cancer Research · doi:10.1158/1538-7445.am2013-5301 · Cited by 7 · see citing works

Fragile X syndrome

Hagerman, R. J., Berry-Kravis, E., Hazlett, H. C., Bailey, D. B., Moine, H., Kooy, R. F., Tassone, F., Gantois, I., Sonenberg, N., Mandel, J. L., et al. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.65 · Cited by 838 · see citing works

A synaptic perspective of fragile X syndrome and autism spectrum Disorders.

Bagni, C., & Zukin, R. S. (2019) · Neuron · doi:10.1016/j.neuron.2019.02.041 · Cited by 326 · see citing works

Mechanistic Target of Rapamycin–Independent Antidepressant Effects of ( R )-Ketamine in a Social Defeat Stress Model

Yang, C., Ren, Q., Qu, Y., Zhang, J., Ma, M., Dong, C., & Hashimoto, K. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.05.016 · Cited by 252 · see citing works

ERK/MAPK signalling in the developing brain: Perturbations and consequences

Iroegbu, J. D., Ijomone, O. K., Femi-Akinlosotu, O. M., & Ijomone, O. M. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.10.009 · Cited by 206 · see citing works

Activation of autophagy rescues synaptic and cognitive deficits in fragile X mice

Yan, J., Porch, M. W., Court-Vazquez, B. L., Bennett, M. V. L., & Zukin, R. S. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1808247115 · Cited by 144 · see citing works

Fragile X syndrome and associated disorders: Clinical aspects and pathology

Salcedo‐Arellano, M. J., Dufour, B. D., McLennan, Y. A., Martínez‐Cerdeño, V., & Hagerman, R. J. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104740 · Cited by 141 · see citing works

Synaptic GluN2A-Containing NMDA Receptors: From Physiology to Pathological Synaptic Plasticity

Franchini, L., Carrano, N., Luca, M. D., & Gardoni, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041538 · Cited by 124 · see citing works

Of Men and Mice: Modeling the Fragile X Syndrome

Dahlhaus, R. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00041 · Cited by 118 · see citing works

Multifarious Functions of the Fragile X Mental Retardation Protein

Davis, J. K., & Broadie, K. S. (2017) · Trends in Genetics · doi:10.1016/j.tig.2017.07.008 · Cited by 118 · see citing works

FMRP has a cell-type-specific role in CA1 pyramidal neurons to regulate autism-related transcripts and circadian memory

Sawicka, K., Hale, C. R., Park, C. Y., Fak, J. J., Gresack, J. E., Driesche, S. J. V., Kang, J. J., Darnell, J. C., & Darnell, R. B. (2019) · eLife · doi:10.7554/elife.46919 · Cited by 113 · see citing works

Aberrant RNA translation in fragile X syndrome: From FMRP mechanisms to emerging therapeutic strategies

Banerjee, A., Ifrim, M. F., Valdez‐Sinon, A. N., Raj, N., & Bassell, G. J. (2018) · Brain Research · doi:10.1016/j.brainres.2018.04.008 · Cited by 103 · see citing works

ERK/MAPK signaling and autism spectrum disorders

Vithayathil, J., Pucilowska, J., & Landreth, G. E. (2018) · Progress in brain research · doi:10.1016/bs.pbr.2018.09.008 · Cited by 101 · see citing works

Metformin for treatment of fragile X syndrome and other neurological disorders

Gantois, I., Popic, J., Khoutorsky, A., & Sonenberg, N. (2019) · Annual Review of Medicine · doi:10.1146/annurev-med-081117-041238 · Cited by 87 · see citing works

Protein synthesis levels are increased in a subset of individuals with fragile X syndrome

Jacquemont, S., Pacini, L., Jønch, A. E., Cencelli, G., Rozenberg, I., He, Y., D’Andrea, L., Pedini, G., Eldeeb, M., Willemsen, R., et al. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy099 · Cited by 68 · see citing works

Audiogenic Seizures in theFmr1Knock-Out Mouse Are Induced byFmr1Deletion in Subcortical, VGlut2-Expressing Excitatory Neurons and Require Deletion in the Inferior Colliculus

Gonzalez, D., Tomasek, M. P., Hays, S. A., Sridhar, V., Ammanuel, S. G., Chang, C.-W., Pawlowski, K. S., Huber, K. M., & Gibson, J. R. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.0886-19.2019 · Cited by 64 · see citing works

Mechanisms underlying auditory processing deficits in Fragile X syndrome

McCullagh, E., Rotschafer, S., Auerbach, B. D., Klug, A., Kaczmarek, L. K., Cramer, K. S., Kulesza, R., Razak, K. A., Lovelace, J., Lu, Y., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201902435r · Cited by 64 · see citing works

New insights into the regulatory function of CYFIP1 in the context of WAVE- and FMRP-containing complexes

Abekhoukh, S., Sahin, H. B., Grossi, M., Zongaro, S., Maurin, T., Madrigal, I., Kazue-Sugioka, D., Raas-Rothschild, A., Doulazmi, M., Carrera, P., et al. (2017) · Disease Models &amp; Mechanisms · doi:10.1242/dmm.025809 · Cited by 59 · see citing works

An evolutionarily conserved ribosome-rescue pathway maintains epidermal homeostasis

Liakath‐Ali, K., Mills, E. W., Sequeira, I., Lichtenberger, B. M., Pisco, A. O., Sipilä, K. H., Mishra, A., Yoshikawa, H., Wu, C. C., Ly, T., et al. (2018) · Nature · doi:10.1038/s41586-018-0032-3 · Cited by 54 · see citing works

Activation of Serotonin 5-HT7 Receptors Modulates Hippocampal Synaptic Plasticity by Stimulation of Adenylate Cyclases and Rescues Learning and Behavior in a Mouse Model of Fragile X Syndrome

Costa, L., Sardone, L. M., Bonaccorso, C. M., D’Antoni, S., Spatuzza, M., Gulisano, W., Tropea, M. R., Puzzo, D., Leopoldo, M., Lacivita, E., et al. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00353 · Cited by 49 · see citing works

Negative Effects of Chronic Rapamycin Treatment on Behavior in a Mouse Model of Fragile X Syndrome

Saré, R. M., Song, A., Loutaev, I., Cook, A. K., Maita, I., Lemons, A. H. S., Sheeler, C. A., & Smith, C. B. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00452 · Cited by 43 · see citing works

Impaired Cognitive Function and Altered Hippocampal Synaptic Plasticity in Mice Lacking Dermatan Sulfotransferase Chst14/D4st1

Li, Q., Wu, X., Na, X.-Y., Ge, B.-Y., Wu, Q., Guo, X., Ntim, M., Zhang, Y., Sun, Y., Yang, J., et al. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00026 · Cited by 41 · see citing works

c-Met up-regulates the expression of PD-L1 through MAPK/NF-κBp65 pathway

Xu, R., Liu, X., Li, A., Li, S., Liang, J., Gao, J., & Tang, X. (2022) · Journal of Molecular Medicine · doi:10.1007/s00109-022-02179-2 · Cited by 40 · see citing works

ERK1/2-dependent BDNF synthesis and signaling is required for the antidepressant effect of microglia stimulation

Lu, X., Liu, H., Cai, Z., Hu, Z., Ye, M., Gu, Y., Wang, Y., Wang, D., Lu, Q., Shen, Z., et al. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.08.005 · Cited by 38 · see citing works

Molecular Biomarkers in Fragile X Syndrome

Zafarullah, M., & Tassone, F. (2019) · Brain Sciences · doi:10.3390/brainsci9050096 · Cited by 36 · see citing works

Neurobiological Mechanisms of Autism Spectrum Disorder and Epilepsy, Insights from Animal Models

Sierra-Arregui, T., Llorente, J., Mı́nguez, P., Tønnesen, J., & Peñagarikano, O. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.02.043 · Cited by 32 · see citing works

Exploring the neuropsychiatric spectrum using high-content functional analysis of single-cell signaling networks

Lago, S. G., Tomasik, J., van Rees, G. F., Ramsey, J. M., Haenisch, F., Cooper, J. D., Broek, J. A., Suarez-Pinilla, P., Ruland, T., Auyeug, B., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-018-0123-4 · Cited by 30 · see citing works

Towards Kinase Inhibitor Therapies for Fragile X Syndrome: Tweaking Twists in the Autism Spectrum Kinase Signaling Network

D’Incal, C., Broos, J., Torfs, T., Kooy, R. F., & Vanden Berghe, W. (2022) · Cells · doi:10.3390/cells11081325 · Cited by 29 · see citing works

Cerebellar contribution to autism-relevant behaviors in fragile X syndrome models

Gibson, J. M., Vazquez, A. H., Yamashiro, K., Jakkamsetti, V., Ren, C., Lei, K., Dentel, B., Pascual, J. M., & Tsai, P. T. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113533 · Cited by 23 · see citing works

Cortical Seizures in FoxG1+/− Mice are Accompanied by Akt/S6 Overactivation, Excitation/Inhibition Imbalance and Impaired Synaptic Transmission

Testa, G., Olimpico, F., Pancrazi, L., Borello, U., Cattaneo, A., Caleo, M., Costa, M., & Mainardi, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174127 · Cited by 24 · see citing works

Effects of the sigma-1 receptor agonist blarcamesine in a murine model of fragile X syndrome: neurobehavioral phenotypes and receptor occupancy

Reyes, S. T., Deacon, R. M. J., Guo, S. G., Altimiras, F. J., Castillo, J. B., van der Wildt, B., Morales, A. P., Park, J. H., Klamer, D., Rosenberg, J., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-94079-7 · Cited by 22 · see citing works

Blocking ERK-DAPK1 Axis Attenuates Glutamate Excitotoxicity in Epilepsy

Gan, C., Zou, Y., Chen, D., Shui, X., Hu, L., Li, R., Zhang, T., Wang, J., Mei, Y., Wang, L., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126370 · Cited by 22 · see citing works

Remodeling Translation Primes CD8+ T-cell Antitumor Immunity

Hurst, K. E., Lawrence, K. A., Robino, R. A., Ball, L. E., Chung, D., & Thaxton, J. E. (2020) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-19-0516 · Cited by 21 · see citing works

Elucidation of Abnormal Extracellular Regulated Kinase (ERK) Signaling and Associations with Syndromic and Non-syndromic Autism

Tiwari, A., Rahi, S., & Mehan, S. (2020) · Current Drug Targets · doi:10.2174/1389450121666201020155010 · Cited by 19 · see citing works

A Clinically Relevant Selective ERK-Pathway Inhibitor Reverses Core Deficits in a Mouse Model of Autism

Murari, K., Abushaibah, A., Rho, J. M., Turner, R. W., & Cheng, N. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2023.104565 · Cited by 19 · see citing works

Dysregulation of translational control signaling in autism spectrum disorders

Hooshmandi, M., Wong, C., & Khoutorsky, A. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109746 · Cited by 17 · see citing works

Loss of Sodium-Activated Potassium Channel Slack and FMRP Differentially Affect Social Behavior in Mice

Bausch, A. E., Ehinger, R., Straubinger, J., Zerfass, P., Nann, Y., & Łukowski, R. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.05.040 · Cited by 18 · see citing works

Agmatine relieves behavioral impairments in Fragile X mice model

Jeon, S. J., Kwon, H., Bae, H. J., Gonzales, E. L., Kim, J.-H., Chung, H. J., Kim, D. H., Ryu, J. H., & Shin, C. Y. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109234 · Cited by 17 · see citing works

Quantitative proteomics and phosphoproteomics of PP2A-PPP2R5D variants reveal deregulation of RPS6 phosphorylation via converging signaling cascades

Smolen, K. A., Papke, C. M., Swingle, M. R., Musiyenko, A., Li, C., Salter, E. A., Camp, A. D., Honkanen, R. E., & Kettenbach, A. N. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105154 · Cited by 17 · see citing works

A Highly Selective MNK Inhibitor Rescues Deficits Associated with Fragile X Syndrome in Mice

Shukla, T. N., de la Peña, J. B., Perish, J. M., Ploski, J. E., Stumpf, C. R., Webster, K. R., Thorn, C. A., & Campbell, Z. T. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00932-4 · Cited by 16 · see citing works

P90 ribosomal S6 kinases: A bona fide target for novel targeted anticancer therapies?

Koutsougianni, F., Alexopoulou, D., Üvez, A., Lamprianidou, A., Sereti, E., Tsimplouli, C., Armutak, E. İ., & DIMAS, K. S. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115488 · Cited by 13 · see citing works

RSK1 and RSK2 as therapeutic targets: an up-to-date snapshot of emerging data

Spirrison, A. N., & Lannigan, D. A. (2024) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2024.2433123 · Cited by 15 · see citing works

Persistently Elevated mTOR Complex 1-S6 Kinase 1 Disrupts DARPP-32–Dependent D1 Dopamine Receptor Signaling and Behaviors

Lin, R., Learman, L. N., Na, C. H., Renuse, S., Chen, K. T., Chen, P. Y., Lee, G.-H., Xiao, B., Resnick, S. M., Troncoso, J. C., et al. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.10.012 · Cited by 16 · see citing works

Epileptic seizures induced by pentylenetetrazole kindling accelerate Alzheimer-like neuropathology in 5×FAD mice

Zou, Y., Wang, C., Li, H., Zhong, M., Lin, J., Hu, Y., Chen, Z., & Gan, C. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1500105 · Cited by 13 · see citing works

Of local translation control and lipid signaling in neurons

Moine, H., & Vitale, N. (2018) · Advances in Biological Regulation · doi:10.1016/j.jbior.2018.09.005 · Cited by 13 · see citing works

Tau reduction attenuates autism-like features in Fmr1 knockout mice

Zhao, S., Jiang, X., Han, L., Jiang, Y., Wang, Y., Meng, J., Zhu, X., Zhang, X., Luo, H., & Zhang, Y.-W. (2023) · Molecular Autism · doi:10.1186/s13229-023-00574-1 · Cited by 12 · see citing works

Fate plasticity of interneuron specification

Mostajo-Radji, M. A., Mancia, W., Breevoort, A., Gonzalez-Ferrer, J., Schweiger, H. E., Lehrer, J., Zhou, L., Schmitz, M. T., Perez, Y., Mukhtar, T., et al. (2025) · iScience · doi:10.1016/j.isci.2025.112295 · Cited by 9 · see citing works

Animal Models for Coffin-Lowry Syndrome: RSK2 and Nervous System Dysfunction

Fischer, M., & Raabe, T. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00106 · Cited by 11 · see citing works

Kinase pathway inhibition restores PSD95 induction in neurons lacking fragile X mental retardation protein

Yang, Y., Yang, G., Jiang, D., Lin, N., Kim, H. J., Jeon, N. L., Lau, A., Chen, L., & Lin, M. Z. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1812056116 · Cited by 10 · see citing works

Antiseizure effects of Lilii Bulbus on pentylenetetrazol kindling-induced seizures in mice: Involvement of Reelin, Netrin-1, and semaphorin

Park, H. R., & Cai, M. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116385 · Cited by 10 · see citing works

PLPPR4 haploinsufficiency causes neurodevelopmental disorders by disrupting synaptic plasticity via mTOR signalling

Li, H., Zhang, Q., Wan, R., Zhou, L., Xu, X., Xu, C., Yuan, Y. J., Xu, Y., Xiang, Y., & Tang, S. (2023) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17899 · Cited by 10 · see citing works

Drosophila RSK Influences the Pace of the Circadian Clock by Negative Regulation of Protein Kinase Shaggy Activity

Beck, K., Hovhanyan, A., Menegazzi, P., Helfrich‐Förster, C., & Raabe, T. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00122 · Cited by 10 · see citing works

Therapeutic efficacy of the BKCa channel opener chlorzoxazone in a mouse model of Fragile X syndrome

Ferraguto, C., Piquemal, M., Lemaire, V., Moreau, M. M., Trazzi, S., Uguagliati, B., Ciani, E., Bertrand, S. S., Louette, E., Bontempi, B., et al. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01956-6 · Cited by 8 · see citing works

Drug Treatments for Neurodevelopmental Disorders: Targeting Signaling Pathways and Homeostasis

Kaufmann, W. E., Luu, S., & Budimirovic, D. B. (2024) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-024-01394-3 · Cited by 8 · see citing works

RNA-seq of human T cells after hematopoietic stem cell transplantation identifies Linc00402 as a regulator of T cell alloimmunity

Peltier, D., Radosevich, M., Ravikumar, V., Pitchiaya, S., Decoville, T., Wood, S. C., Hou, G., Zajac, C. K., Oravecz-Wilson, K. I., Sokol, D., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz0316 · Cited by 8 · see citing works

Effects of the presence and absence of amino acids on translation, signaling, and long‐term depression in hippocampal slices from Fmr1 knockout mice

Cooke, S. K., Russin, J., Moulton, K., Nadel, J., Loutaev, I., Gu, Q., Li, Z., & Smith, C. B. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14874 · Cited by 7 · see citing works

miR-483-5p orchestrates the initiation of protein synthesis by facilitating the decrease in phosphorylated Ser209eIF4E and 4E-BP1 levels

Nagaraj, S., Stankiewicz-Drogoń, A., Darzynkiewicz, E., Wojda, U., & Grzela, R. (2024) · Scientific Reports · doi:10.1038/s41598-024-54154-1 · Cited by 6 · see citing works

Brain cell signaling abnormalities are detected in blood in a murine model of Fragile X syndrome and corrected by Sigma‐1 receptor agonist Blarcamesine

Cogram, P., Deacon, R. M. J., Klamer, D., Rebowe, N., Sprouse, J. S., Reyes, S. T., Missling, C. U., & Kaufmann, W. E. (2022) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.62853 · Cited by 5 · see citing works

Aggression Results in the Phosphorylation of ERK1/2 in the Nucleus Accumbens and the Dephosphorylation of mTOR in the Medial Prefrontal Cortex in Female Syrian Hamsters

Borland, J. M., Dempsey, D. A., Peyla, A. C., Hall, M. A. L., Kohut-Jackson, A. L., Mermelstein, P. G., & Meisel, R. L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021379 · Cited by 5 · see citing works

Progranulin is an FMRP target that influences macroorchidism but not behaviour in a mouse model of Fragile X Syndrome

Life, B. E., Bettio, L. E. B., Gantois, I., Christie, B. R., & Leavitt, B. R. (2023) · Current Research in Neurobiology · doi:10.1016/j.crneur.2023.100094 · Cited by 5 · see citing works

Restoration of Normal NF1 Function with Antisense Morpholino Treatment of Recurrent Pathogenic Patient-Specific Variant c.1466A>G; p.Y489C

Awad, E. K., Moore, M., Liu, H., Ciszewski, L., Lambert, L. J., Korf, B. R., Popplewell, L. J., Kesterson, R. A., & WALLIS, D. E. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11121320 · Cited by 5 · see citing works

Blunted type-5 metabotropic glutamate receptor-mediated polyphosphoinositide hydrolysis in two mouse models of monogenic autism

Menna, L. D., Orlando, R., D’Errico, G., Ginerete, R. P., Machaczka, A., Bonaccorso, C. M., Arena, A., Spatuzza, M., Celli, R., Alborghetti, M., et al. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109642 · Cited by 5 · see citing works

Prevention of post-ischemic seizure by rapamycin is associated with deactivation of mTOR and ERK1/2 pathways in hyperglycemic rats

Yang, X. C., Hei, C., Liu, P., & Li, P. A. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.09.096 · Cited by 5 · see citing works

Pharmacological Treatments for Fragile X Syndrome Based on Synaptic Dysfunction

Telias, M. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666191102165206 · Cited by 4 · see citing works

SRC family kinase inhibition rescues molecular and behavioral phenotypes, but not protein interaction network dynamics, in a mouse model of Fragile X syndrome

Stamenković, V., Lautz, J. D., Harsh, F. M., & Smith, S. E. P. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02418-7 · Cited by 3 · see citing works

Contribution of astrocytic calcium signaling to auditory hypersensitivity in a mouse model of fragile X syndrome

Bergdolt, L., Anding, A., Alshaqi, O., Arbabi, Z., Douchey, M., Eldridge, E., Hoffman, K., Reid, A., Sapkota, K., Monaghan, D. T., et al. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107355 · Cited by 3 · see citing works

Growth-suppressor microRNAs mediate synaptic overgrowth and behavioral deficits in Fragile X mental retardation protein deficiency

Subramanian, M. P., Mills, W. T., Paranjpe, M. D., Onuchukwu, U. S., Inamdar, M., Maytin, A. R., Li, X., Pomerantz, J. L., & Meffert, M. K. (2023) · iScience · doi:10.1016/j.isci.2023.108676 · Cited by 3 · see citing works

Intracellular Signaling Networks in Fragile X Syndrome: Approaches to Drug Discovery and Therapeutics

Groß, C., & Bhattacharya, A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804461-2.00011-1 · Cited by 3 · see citing works

Pioglitazone improves deficits of Fmr1 -KO mouse model of Fragile X syndrome by interfering with excessive diacylglycerol signalingPreprint

Geoffroy, A., Habbas, K., Zámbó, B., Schramm, L., Duchon, A., Flatter, E., Fouillen, L., Zumsteg, J., Heintz, D., Mandel, J., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.22.301762 · Cited by 3 · see citing works

A Two-Hit Approach Inducing Flurothyl Seizures in Fmr1 Knockout Mice Impacts Anxiety and Repetitive Behaviors

Blandin, K. J., Narvaiz, D. A., Sullens, D. G., Womble, P. D., Hodges, S. L., Binder, M. S., Faust, A. M., Nguyen, P. H., Pranske, Z. J., & Lugo, J. N. (2024) · Brain Sciences · doi:10.3390/brainsci14090892 · Cited by 2 · see citing works

Dysregulation of Glu-GABA and reduction of triglycerides contribute to valproic acid-induced autism model in zebrafish

Sun, Q., Huang, X., Long, H., Guo, J., Zhang, R., Daru, L., Yao, H., Jiang, K., & ., Y. P. (2025) · Journal of Lipid Research · doi:10.1016/j.jlr.2025.100911 · Cited by 2 · see citing works

Altered Auditory Maturation in Fragile X Syndrome and Its Involvement in Audiogenic Seizure Susceptibility

Möhrle, D., Ma, D., Xue, W., Yan, J., & Cheng, N. (2025) · Autism Research · doi:10.1002/aur.70152 · Cited by 3 · see citing works

Suppression of astrocyte BMP signaling improves molecular signatures and functional deficits in a fragile X syndrome mouse model

Deng, J., Paumier, A., Labarta-Bajo, L., Brandebura, A. N., Andrews, N., Kahn, S. B., Bassil, R., Tao, T., Pinto, A. F. M., Diedrich, J. K., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-71919-6 · Cited by 2 · see citing works

The longevity of queen honey bees (Apis mellifera) is associated with the increase of cellular activities through the cAMP/PKA and RAS/MAPK signaling pathways

Hsu, C., Weng, Y., & Chen, C. (2022) · Apidologie · doi:10.1007/s13592-022-00976-9 · Cited by 2 · see citing works

Novel presynaptic assay system revealed that metformin ameliorates exaggerated synaptic release and Munc18-1 accumulation in presynapses of neurons from Fragile X syndrome mouse model

Takeda, R., Ishii, R., Parvin, S., Shiozawa, A., Nogi, T., & Sasaki, Y. (2023) · Neuroscience Letters · doi:10.1016/j.neulet.2023.137317 · Cited by 2 · see citing works

Quantitative proteomics and phosphoproteomics of PPP2R5D variants reveal deregulation of RPS6 phosphorylation through converging signaling cascadesPreprint

Smolen, K. A., Papke, C. M., Swingle, M. R., Musiyenko, A., Li, C., Camp, A., Honkanen, R. E., & Kettenbach, A. N. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.27.534397 · Cited by 2 · see citing works

Human pluripotent stem cells in the research of Fragile X Syndrome

Telias, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85764-2.00012-0

Identification of Essential Temperature-Stressed Genes From Apis mellifera Hypopharyngeal Glands Transcriptomes Under Variable TemperaturesPreprint

Maigoro, A. Y., Lee, J., Lee, S., & Kwon, H. W. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.22.568201

Astrocytic contribution to auditory hypersensitivity in a mouse model of fragile X syndromePreprint

Bergdolt, L., Anding, A., Alshaqi, O., Arbabi, Z., Douchey, M., Eldridge, E., Hoffman, K., Reid, A., Sapkota, K., Padmashri, R., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.14.638346

Additional file 1 of Tau reduction attenuates autism-like features in Fmr1 knockout mice

Zhao, S., Jiang, X., Han, L., Jiang, Y., Wang, Y., Meng, J., Zhu, X., Zhang, X., Luo, H., & Zhang, Y.-W. (2023) · Figshare · doi:10.6084/m9.figshare.24522666

Etude de la neurogenèse hippocampique adulte et des fonctions cognitives chez trois souris modèles de déficience intellectuelle

Castillon, C. (2018) · theses.fr (ABES) · doi:10.70675/3cf539d4z8f28z44d5zb94dzf27b0404597b

Etude du développement cérébral et cognitif d'un modèle murin de la déficience intellectuelle du syndrome de Coffin-Lowry au cours de la période postnatale

Gonzalez, L. (2022) · doi:10.70675/1a46df63z254ez4f15zbd29ze4522055d91b

BKCa channels as therapeutic targets in neurodevelopmental disorders : focus on acoustic dysfunction

Ferraguto, C. (2024) · theses.fr (ABES) · doi:10.70675/38217611z1b01z43f4zb4b0z72d28aca79c3

Dentate Gyrus ERK1/2-BDNF Signaling is Required for the Antidepressant Effect of Microglial Stimulation in a Male Mouse Model of Depression Induced by Adolescent Nicotine Exposure

Ji, W., Wu, S., Ye, M., Zhang, L., Hong, J., Yan, L., Pan, H., Huang, C., Zhang, Y., & Wang, H. (2026) · Neurochemical Research · doi:10.1007/s11064-026-04811-w

The Role of the Immunoglobulin Superfamily of Cell Adhesion Molecules in Intellectual Disability

Zaman, N., Bui, K., & Sytnyk, V. (2026) · Cells · doi:10.3390/cells15191801

Activation of the extracellular signal‐regulated kinase pathway contributes to the behavioral deficit of fragile x‐syndrome

Wang, X., Snape, M., Klann, E., Stone, J. G., Singh, A., Petersen, R. B., Castellani, R. J., Casadesús, G., Smith, M. A., & Zhu, X. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07722.x · Cited by 91 · see citing works

Hypersensitivity to mGluR5 and ERK1/2 Leads to Excessive Protein Synthesis in the Hippocampus of a Mouse Model of Fragile X Syndrome

Osterweil, E. K., Krueger, D. D., Reinhold, K., & Bear, M. F. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3888-10.2010 · Cited by 384 · see citing works

Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome

Hoeffer, C. A., Sanchez, E., Hagerman, R. J., Mu, Y., Nguyen, D. V., Wong, H., Whelan, A. M., Zukin, R. S., Klann, E., & Tassone, F. (2012) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2012.00768.x · Cited by 198 · see citing works

Potential treatment strategies and underlying mechanisms in the Fragile X Syndrome mouse and rat models

Muscas, M. (2019) · doi:10.7488/era/229

FYN, a Novel Target of Fragile X Mental Retardation Protein, Potentially Underlies ERK1/2 Hyperactivation in Fragile X Syndrome

Huang, W., Jiang, L., Zhu, Y., Duan, R., Xue, J., & Xia, Q. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06115-0